C.H. Robinson (CHRW)

Total Costs & Expenses

$16.16B

TTM · Period ending: · USD

CHRW logo

CHRW Total Costs & Expenses

Latest reported$16.16B
CHRW TTM Total Costs & Expenses ($1.56B → $16.16B)
High-resolution chart · PNG

CHRW total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

C.H. Robinson Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
16,162,894,000
15,405,163,000
15,437,802,000
15,707,378,000
16,255,890,000
16,640,524,000
17,055,815,000
17,169,416,000
16,932,402,000
16,916,377,000
17,081,836,000
17,870,165,000
19,370,424,000
21,410,001,000
23,429,843,000
24,741,498,000
24,966,657,000
23,909,969,000
22,020,030,000
20,148,238,000
18,251,873,000
16,418,810,000
15,533,838,000
14,847,708,000
14,446,194,000
14,688,440,000
14,519,532,000
14,745,403,000
15,136,283,000
15,512,007,000
15,719,089,000
15,585,608,000
15,129,667,000
14,600,836,000
14,094,261,000
13,566,761,000
13,121,262,000
12,659,058,000
12,306,882,000
12,081,746,000
12,123,801,000
12,373,800,000
12,617,774,000
12,790,974,000
12,868,457,000
12,855,000,000
12,721,649,000
12,549,944,000
12,426,229,000
12,229,479,000
12,069,426,000
11,908,929,000
11,461,771,000
11,126,785,000
10,683,793,000
10,242,850,000
10,060,661,000
9,817,428,000
9,643,616,000
9,408,571,000
9,151,632,000
8,921,592,000
8,651,445,000
8,355,769,000
7,901,747,000
7,380,356,000
6,992,378,000
6,939,489,000
7,307,461,000
7,708,525,000
8,007,028,000
8,013,458,000
7,578,806,000
7,151,538,000
6,806,539,000
6,519,606,000
6,388,657,000
6,235,804,000
6,138,349,000
6,097,008,000
5,894,386,000
5,622,120,000
5,362,587,000
5,003,664,000
4,666,708,000
4,366,479,000
4,118,770,000
3,882,011,000
3,691,746,000
3,556,216,000
3,430,061,000
3,334,938,000
3,292,289,000
3,204,984,000
3,137,893,000
3,080,627,000
3,000,493,000
2,958,881,000
2,955,798,000
2,916,136,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.